January 18, 2019: This report focuses on the global Life Sciences Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Life Sciences Software development in United States, Europe and China.
Life science deals with the scientific study of organisms such as microorganism, human being, and animals. It includes broad range of areas of study such as biology, anatomy, health sciences, and medical sciences. The software used in life science allows a user to increase efficacy & reduce the cost of deploying valuable IT infrastructure. For instance, software as a service (SaaS) model for life science offers a pay per use model, which provides more feasibility to store patient data.
Download sample Copy of This Report at: https://www.radiantinsights.com/research/global-life-sciences-software-market-size-status-and-forecast-2018-2025/request-sample
Rise in need for the improvement of operational efficiency and enhanced performance of the organization by collection & management of data efficiently by using life sciences software drive the growth of the global life sciences software market. However, high cost associated with the implementation of software impedes the market growth. Adoption of mergers and acquisitions (M&A) strategies among various life sciences companies is expected to offer a major opportunity for market expansion.
In 2017, the global Life Sciences Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
Browse Full Report With TOC @ https://www.radiantinsights.com/research/global-life-sciences-software-market-size-status-and-forecast-2018-2025
The key players covered in this study
- QuintilesIMS Incorporated
- Autodesk Inc
- PAREXEL International Corporation
- Model N
- Dassault Systemes
- CSC
- International Business Machines Corp
- SAP SE
- Veeva Systems
- Medidata Solutions, Inc
Market segment by Type, the product can be split into
- Cloud-based
- On-premises
Market segment by Application, split into
- Pharmaceuticals
- Biotechnology
- Others
The study objectives of this report are:
- To analyze global Life Sciences Software status, future forecast, growth opportunity, key market and key players.
- To present the Life Sciences Software development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Life Sciences Software are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Blog URL: http://ictmarketforecasts.wordpress.com
Life Sciences BPO Market: IntroductionTransparency Market Research has published a new report titled, ‘Global Life Sciences BPO Market’.
According to the report, the global life sciences BPO market was valued at ~US$ 214 Bn in 2018 and is projected to expand at a CAGR of ~8% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1782Broad and Growing Product Pipeline to Drive Adoption of Advanced Life Sciences BPORise in demand for new drugs and novel therapies for treatment of diseases such as cancer and immunological disorders coupled with the evolving research & development process has increased the number of compounds in pipeline in the last decade.
This in turn drives the global life sciences BPO market.Efforts to Optimize Costs and Development TimeEscalating costs of conducting clinical trials, requirement of data quality, enrollment targets, financial demands regarding setting up of a clinical research practice, and other management related activities drive the outsourcing services.
According to the Tufts Center for the Study of Drug Development, outsourcing to CROs has supported companies in keeping R head counts stable, even though the number of active clinical trials across the world has increased by 80%.
Moreover, trials outsourced to CROs are, on average, completed 30% sooner than in-house clinical trials, providing an average timesaving of four to five months.Request COVID Analysis on Life Sciences BPO Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1782Contract Manufacturing Organizations to Lead Global MarketBased on service type, the contract manufacturing organizations segment dominated the global market in 2018.
Significant increase in research and development costs, technological developments, and product innovation, which accounts for high R costs prompt several pharmaceutical and medical device companies to outsource preclinical services to CROs.
